155 related articles for article (PubMed ID: 37195291)
1. Therapy results in pediatric Hodgkin lymphoma - does less mean better? Experience from a single children's oncology center.
Stankiewicz J; Kołtan A; Demidowicz E; Bartoszewicz N; Kołtan S; Czyżewski K; Richert-Przygońska M; Dębski R; Pogorzała M; Tejza B; Cisek J; Księżniakiewicz P; Jatczak-Gaca A; Marjańska A; Salamon M; Dąbrowska A; Urbańczyk A; Grześk E; Jaremek K; Łęcka M; Grochowska O; Styczyński J
Ann Hematol; 2023 Aug; 102(8):2109-2117. PubMed ID: 37195291
[TBL] [Abstract][Full Text] [Related]
2. Ifosfamide and vinorelbine is an effective reinduction regimen in children with refractory/relapsed Hodgkin lymphoma, AHOD00P1: a children's oncology group report.
Trippett TM; Schwartz CL; Guillerman RP; Gamis AS; Gardner S; Hogan S; London WB; Chen L; de Alarcon P
Pediatr Blood Cancer; 2015 Jan; 62(1):60-4. PubMed ID: 25308760
[TBL] [Abstract][Full Text] [Related]
3. Survival by age in paediatric and adolescent patients with Hodgkin lymphoma: a retrospective pooled analysis of children's oncology group trials.
Kahn JM; Pei Q; Friedman DL; Kaplan J; Keller FG; Hodgson D; Wu Y; Appel BE; Bhatia S; Henderson TO; Schwartz CL; Kelly KM; Castellino SM
Lancet Haematol; 2022 Jan; 9(1):e49-e57. PubMed ID: 34971582
[TBL] [Abstract][Full Text] [Related]
4. [Influence of age on treatment results in children and adolescents with Hodgkin's disease].
Balwierz W; Moryl-Bujakowska A; Depowska T; Klekawka T; Stanuch H; Matysiak M; Sopyło B; Kołakowska-Mrozowska B; Krenke K; Chybicka A; Raś M; Sońta-Jakimczyk D; Moszant A; Wachowiak J; Kaczmarek-Kanold M; Kowalczyk J; Odój T; Balcerska A; Drozyńska E; Wysocki M; Kołtan A; Krawczuk-Rybak M; Stolarska M
Przegl Lek; 2004; 61 Suppl 2():40-4. PubMed ID: 15686044
[TBL] [Abstract][Full Text] [Related]
5. Minimal Treatment of Low-Risk, Pediatric Lymphocyte-Predominant Hodgkin Lymphoma: A Report From the Children's Oncology Group.
Appel BE; Chen L; Buxton AB; Hutchison RE; Hodgson DC; Ehrlich PF; Constine LS; Schwartz CL
J Clin Oncol; 2016 Jul; 34(20):2372-9. PubMed ID: 27185849
[TBL] [Abstract][Full Text] [Related]
6. Outcome of children with nodular lymphocyte predominant Hodgkin lymphoma - a Children's Cancer and Leukaemia Group report.
Hall GW; Katzilakis N; Pinkerton CR; Nicolin G; Ashley S; McCarthy K; Daw S; Hewitt M; Wallace WH; Shankar A
Br J Haematol; 2007 Sep; 138(6):761-8. PubMed ID: 17760808
[TBL] [Abstract][Full Text] [Related]
7. [Clinical pathologic characteristics and treatment outcomes of 19 relapsed pediatric B-cell lymphoma].
Huang S; Jin L; Yang J; Duan YL; Zhang M; Zhou CJ; Ma XL; Zhang YH
Zhonghua Er Ke Za Zhi; 2017 Oct; 55(10):748-753. PubMed ID: 29050112
[No Abstract] [Full Text] [Related]
8. Current approaches to the management of pediatric Hodgkin lymphoma.
Freed J; Kelly KM
Paediatr Drugs; 2010 Apr; 12(2):85-98. PubMed ID: 20218745
[TBL] [Abstract][Full Text] [Related]
9. [Application of anti-programmed cell death protein 1 antibody in children with refractory or relapsed Hodgkin lymphoma].
Li Y; Duan YL; Huang M; Zhang L; Jin YG; Zhang XL; Wang X
Zhonghua Er Ke Za Zhi; 2022 Jun; 60(6):573-577. PubMed ID: 35658365
[No Abstract] [Full Text] [Related]
10. Treatment outcome in children and adolescents with relapsed Hodgkin lymphoma--results of the UK HD3 relapse treatment strategy.
Shankar A; Hayward J; Kirkwood A; McCarthy K; Hewitt M; Morland B; Daw S
Br J Haematol; 2014 May; 165(4):534-44. PubMed ID: 24754633
[TBL] [Abstract][Full Text] [Related]
11. Patterns of Initial Relapse from a Phase 3 Study of Response-Based Therapy for High-Risk Hodgkin Lymphoma (AHOD0831): A Report from the Children's Oncology Group.
Parikh RR; Kelly KM; Hodgson DC; Hoppe BS; McCarten KM; Karolczuk K; Pei Q; Wu Y; Cho SY; Schwartz C; Cole PD; Roberts K
Int J Radiat Oncol Biol Phys; 2022 Mar; 112(4):890-900. PubMed ID: 34767937
[TBL] [Abstract][Full Text] [Related]
12. Dose-dense brentuximab vedotin plus ifosfamide, carboplatin, and etoposide for second-line treatment of relapsed or refractory classical Hodgkin lymphoma: a single centre, phase 1/2 study.
Lynch RC; Cassaday RD; Smith SD; Fromm JR; Cowan AJ; Warren EH; Shadman MS; Shustov A; Till BG; Ujjani CS; Libby EN; Philip M; Coye H; Martino CN; Bhark SL; Morris K; Rasmussen H; Behnia S; Voutsinas J; Gopal AK
Lancet Haematol; 2021 Aug; 8(8):e562-e571. PubMed ID: 34329577
[TBL] [Abstract][Full Text] [Related]
13. The effect of gemcitabine, dexamethasone, and cisplatin chemotherapy in relapsed/refractory NHL and HL patients: A single center experience.
Batgi H; Merdin A; Dal MS; Kızıl Çakar M; Yıldız J; Başçı S; Uncu Ulu B; Yiğenoğlu TN; Darçın T; Şahin D; Bakırtaş M; Tetik A; İskender D; Altuntaş F
J Oncol Pharm Pract; 2020 Dec; 26(8):1857-1863. PubMed ID: 32098553
[TBL] [Abstract][Full Text] [Related]
14. Prognostic factors and long-term outcome of autologous haematopoietic stem cell transplantation following a uniform-modified BEAM-conditioning regimen for patients with refractory or relapsed Hodgkin lymphoma: a single-center experience.
Czyz A; Lojko-Dankowska A; Dytfeld D; Nowicki A; Gil L; Matuszak M; Kozlowska-Skrzypczak M; Kazmierczak M; Bembnista E; Komarnicki M
Med Oncol; 2013; 30(3):611. PubMed ID: 23702734
[TBL] [Abstract][Full Text] [Related]
15. Management of nodular lymphocyte predominant Hodgkin lymphoma in the modern era.
King MT; Donaldson SS; Link MP; Natkunam Y; Advani RH; Hoppe RT
Int J Radiat Oncol Biol Phys; 2015 May; 92(1):67-75. PubMed ID: 25863755
[TBL] [Abstract][Full Text] [Related]
16. [The incidence and treatment of the first relapse in children with Hodgkin's disease].
Balwierz W; Moryl-Bujakowska A; Bogusławska-Jaworska J; Pisarek J; Raś M; Sońta-Jakimczyk D; Janik-Moszant A; Rokicka-Milewska R; Sopylo B; Kolakowska-Mrozowska B; Kołecki P; Kaczmarek-Kanold M; Kowalczyk J; Odój T; Matysiak M; Newecka-Samól T
Med Wieku Rozwoj; 2000; 4(1 Suppl 2):73-84. PubMed ID: 12021465
[TBL] [Abstract][Full Text] [Related]
17. Relapsed and refractory Hodgkin lymphoma: transplantation strategies and novel therapeutic options.
David KA; Mauro L; Evens AM
Curr Treat Options Oncol; 2007 Oct; 8(5):352-74. PubMed ID: 18214690
[TBL] [Abstract][Full Text] [Related]
18. [Diagnosis and treatment of anaplastic large-cell lymphoma in children and adolescents: a retrospective multicenter survey study].
;
Zhonghua Er Ke Za Zhi; 2017 Mar; 55(3):194-199. PubMed ID: 28273702
[No Abstract] [Full Text] [Related]
19. [Hodgkin's lymphoma in adolescents: where to treat it--in an adult or pediatric institution?].
Müller J; Molnár Z; Illés A; Csóka M; Jakab Z; Deák B; Schneider T; Várady E; Rosta A; Simon Z; Keresztes K; Gergely L; Kovács G
Orv Hetil; 2008 Nov; 149(47):2221-7. PubMed ID: 19004744
[TBL] [Abstract][Full Text] [Related]
20. Nodular lymphocyte predominant Hodgkin lymphoma: a Lymphoma Study Association retrospective study.
Lazarovici J; Dartigues P; Brice P; Obéric L; Gaillard I; Hunault-Berger M; Broussais-Guillaumot F; Gyan E; Bologna S; Nicolas-Virelizier E; Touati M; Casasnovas O; Delarue R; Orsini-Piocelle F; Stamatoullas A; Gabarre J; Fornecker LM; Gastinne T; Peyrade F; Roland V; Bachy E; André M; Mounier N; Fermé C
Haematologica; 2015 Dec; 100(12):1579-86. PubMed ID: 26430172
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
